SlideShare a Scribd company logo
Prognostic value
of multiple differential
diagnosis
for optic nerve head by
OCT Angio
Naglaa Hassan
MIOR
OCT A
Optical Coherence Tomography Angiography (OCT-A)
is an imaging modality that can be used to characterize
vasculature in various retinal layers, providing
quantitative assessment of the microcirculation in the
optic nerve head and peripapillary region
There are some vascular parameters:
vessel density en face
vessel density inside disc spacing between large vessels
spacing between small vessels outside the disc
Normal eyes have
a higher vessel density, higher vessel density inside disc,
lower spacing between large vessels and small vessels.
 NFLP = nerve fiber layer plexus GCLP = ganglion cell layer plexus;
ICP = intermediate capillary plexus; DCP = deep capillary plexus.
 The NFLP and GCLP can be combined superficial vascular
complex (SVC), which contain both large vessels and capillaries.
 The ICP and DCP can be combined into deep vascular complex
OCT-A can play a pivotal role in the detection,
differentiation and monitoring of a wide range of ONH
disorders.
OCT-A can provides valuable data about the
structural changes of the retinal and optic nerve
vascular network
It can be used for monitoring the disease
progression .
Color-coded peripapillary OCTA images with four different ONH diseases.
A) Compression due to optic nerve head drusen
B) Retinal vein occlusion earlier in life
C) Chronic non-arteritic anterior ischemic optic neuropathy,
D) Advanced glaucoma
OCTA in
ONH compressive disorders
(Drusen)
Reduced vascular density consistent with the blue areas on color
vascular density map in the both eyes
Optic disc Drusen
Optic disc drusen ( multi modal imaging )
SCP of optic disc (OCTA) with large vessel removal, annulus region of
interest, and demarcation of the four quadrants
vessel density heat map,
and vessel complexity heat map.
Vessel area density and vessel complexity index are calculated and
represent area occupied by vessel divided by total area and branching
complexity of the perfused vasculature, respectively .
For ease of comparison, these values are shown on a linear color scale
Optic disc drusen does not require treatment,
and patients generally have good visual
prognosis.
There is currently no effective treatment for
patients who have gradual loss of visual fields
OCTA in Retinal vein
occlusion
Inside disc Vessel Density (VD) (F), measured inside the optic
disc boundary and peripapillary VD, calculated for the region
of 750 μm-wide elliptical annulus extending from the optic
disc boundary.
Optic nerve vessel density changes before (A) and after 4-months
(D) from intravitreal anti-(VEGF) injection.
Inside disc and peripapillary VD OCTA showed increase in the
papillary area in patients affected by CRVO after anti-VEGF
therapy.
Follow-up OCT vertical scans show a reduction of macular edema
from baseline to 4-months (This area could represent a new region
of interest to study microvasculature changes concomitant with
severe macular edema.
Prognostic
value
OCTA in
Neurodegenerative diseases
Anterior Ischaemic Optic Neuropathy
Multimodal analysis of right eye in an AION The fundus
examination show a moderately pale optic disc .
OCTA scans a reduction of the OCTA whole perfusion density and
circumpapillary density (even considering the color-coded flow
density map) in the superior Hemifield topographically correlated
with the ONH and RNFL damage.
In NAION, it has been found that there is significant
sectorial capillary density reduction and subsequent
decrease in the blood flow to the corresponding region of
the optic nerve head.
1st presentation, diffuse edema with normal vascular perfusion
was observed then A month later, optic disc atrophy was
established with Extensive areas of reduced perfusion are
observed in the peripapillary area.
Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)
MS
Optic neuritis can be the initial symptom in approximately
25% of patients
up to 50% of MS patients will suffer from at least one episode
of optic neuritis during the course of their disease
OCT-A findings in MS include significant reduction of the blood
flow within the parafoveal region and the optic nerve head.
It is still not clear why the blood flow of the retina and optic
nerve is reduced in MS patients.
Disc OCT-A of a healthy control subject.
Right side: Disc OCT-A of an optic neuritis disc showing reduced
density of the optic nerve head blood vessel network.
This implies reduced blood flow on the optic nerve head.
OCTA in
Glaucoma
Among the glaucoma ,glaucomatous eyes, the spacing between
large vessels was significantly higher in moderate and severe
glaucoma grades than in early glaucoma
Vessel density of the optic disc, peripapillary Angio flow density
map (PAFD) displays loss of the retinal nerve fiber layer in a
patient diagnosed with glaucoma.
 OCT-A vessel density is lower in glaucoma patients compared
with healthy and glaucoma suspects
 The Diagnostic accuracy of OCT-A and the ability to
noninvasively evaluate the capillary networks shows promise for
prognostic value for characterizing glaucomatous retinal
vascular changes and may have a role in glaucoma management.
 Also determination whether a lower vessel density found in
glaucoma patients precedes or follows optic nerve damage and
whether this information can be used to improve glaucoma
management.
A) untreated eye with high intraocular pressure.
B) The same eye one month later under combined intraocular
pressure lowering medication and with more than 50%
intraocular pressure reduction
The peripapillary vessel density map shows a clear increase in
capillary perfusion
Prognostic
value
1-OCT-A can play a pivotal role in differentiation and monitoring
of a wide range of ONH disorders.
2-OCTA can be used for the development of biomarkers to monitor
the disease progression .
3-Not only RNFL analysis. .O.N.H micro vasculature does matter as
the same important .
4-O.N.H and peri papillary area could represent a new region of
interest to study microvasculature changes.
Take home
message
Prognostic value of multiple differential diagnosis of ONH by OCT Angio.pptx

More Related Content

Similar to Prognostic value of multiple differential diagnosis of ONH by OCT Angio.pptx

Optic coherence tomography
Optic coherence tomographyOptic coherence tomography
Optic coherence tomography
NeurologyKota
 
AMA series design
AMA series designAMA series design
AMA series design
Rebecca Evans
 
Pachychoroid spectrum diseases
Pachychoroid spectrum diseasesPachychoroid spectrum diseases
Pachychoroid spectrum diseases
Yasuo Yanagi
 
Oct updateS -AJAY DUDANI
Oct updateS -AJAY DUDANIOct updateS -AJAY DUDANI
Oct updateS -AJAY DUDANI
AjayDudani1
 
Oct angiogram
Oct angiogramOct angiogram
Oct angiogram
Md Afzal Mahfuzullah
 
PPT (Terapi anti–vascular endothelial growth factor) salinan.pptx
PPT (Terapi anti–vascular endothelial growth factor) salinan.pptxPPT (Terapi anti–vascular endothelial growth factor) salinan.pptx
PPT (Terapi anti–vascular endothelial growth factor) salinan.pptx
ryaalwi
 
FOCAL CHOROIDAL EXCAVATION IN EYES WITH CENTRAL SEROUS ‎CHORIORETINOPATHY ‎
FOCAL CHOROIDAL EXCAVATION IN EYES WITH CENTRAL SEROUS ‎CHORIORETINOPATHY ‎FOCAL CHOROIDAL EXCAVATION IN EYES WITH CENTRAL SEROUS ‎CHORIORETINOPATHY ‎
FOCAL CHOROIDAL EXCAVATION IN EYES WITH CENTRAL SEROUS ‎CHORIORETINOPATHY ‎
Abdallah Ellabban
 
Focal choroidal excavation in eyes with central serous chorioretinopathy
Focal choroidal excavation in eyes with central serous chorioretinopathy Focal choroidal excavation in eyes with central serous chorioretinopathy
Focal choroidal excavation in eyes with central serous chorioretinopathy
Abdallah Ellabban
 
Focal choroidal excavation in eyes with central serous chorioretinopathy
Focal choroidal excavation in eyes with central serous chorioretinopathyFocal choroidal excavation in eyes with central serous chorioretinopathy
Focal choroidal excavation in eyes with central serous chorioretinopathy
Abdallah Ellabban
 
Retinal vascular occlusions
Retinal vascular occlusions Retinal vascular occlusions
Retinal vascular occlusions
Pooja Kandula
 
Retinal imaging
Retinal imagingRetinal imaging
Retinal imaging
ashish markan
 
Solix brochure
Solix brochureSolix brochure
Solix brochure
Haag-Streit UK (HS-UK)
 
Criterios diagnosticos en glaucoma
Criterios diagnosticos en glaucomaCriterios diagnosticos en glaucoma
Criterios diagnosticos en glaucoma
Melissa Garcia Felix
 
choroidal-thickness after intravitreal ranibizumab injection
choroidal-thickness after intravitreal ranibizumab injectionchoroidal-thickness after intravitreal ranibizumab injection
choroidal-thickness after intravitreal ranibizumab injection
Abdallah Ellabban
 
Optical coherence tomography
Optical coherence tomographyOptical coherence tomography
Optical coherence tomography
Sinan çalışkan
 
SOLIX Essential Brochure
SOLIX Essential Brochure SOLIX Essential Brochure
SOLIX Essential Brochure
Haag-Streit UK (HS-UK)
 
CRVO AND NVG MANAGEMENT 2016
CRVO AND NVG MANAGEMENT  2016CRVO AND NVG MANAGEMENT  2016
CRVO AND NVG MANAGEMENT 2016
DINESH and SONALEE
 
Polypoidal Choroidal
Polypoidal Choroidal Polypoidal Choroidal
Polypoidal Choroidal
Dr. Mominul Islam, eye consultant
 
Dissertation
DissertationDissertation
Dissertation
nadiaerum
 
OCTA and Glaucoma Detection.
OCTA and Glaucoma Detection.  OCTA and Glaucoma Detection.
OCTA and Glaucoma Detection.
Dr. Abubakar Bosso
 

Similar to Prognostic value of multiple differential diagnosis of ONH by OCT Angio.pptx (20)

Optic coherence tomography
Optic coherence tomographyOptic coherence tomography
Optic coherence tomography
 
AMA series design
AMA series designAMA series design
AMA series design
 
Pachychoroid spectrum diseases
Pachychoroid spectrum diseasesPachychoroid spectrum diseases
Pachychoroid spectrum diseases
 
Oct updateS -AJAY DUDANI
Oct updateS -AJAY DUDANIOct updateS -AJAY DUDANI
Oct updateS -AJAY DUDANI
 
Oct angiogram
Oct angiogramOct angiogram
Oct angiogram
 
PPT (Terapi anti–vascular endothelial growth factor) salinan.pptx
PPT (Terapi anti–vascular endothelial growth factor) salinan.pptxPPT (Terapi anti–vascular endothelial growth factor) salinan.pptx
PPT (Terapi anti–vascular endothelial growth factor) salinan.pptx
 
FOCAL CHOROIDAL EXCAVATION IN EYES WITH CENTRAL SEROUS ‎CHORIORETINOPATHY ‎
FOCAL CHOROIDAL EXCAVATION IN EYES WITH CENTRAL SEROUS ‎CHORIORETINOPATHY ‎FOCAL CHOROIDAL EXCAVATION IN EYES WITH CENTRAL SEROUS ‎CHORIORETINOPATHY ‎
FOCAL CHOROIDAL EXCAVATION IN EYES WITH CENTRAL SEROUS ‎CHORIORETINOPATHY ‎
 
Focal choroidal excavation in eyes with central serous chorioretinopathy
Focal choroidal excavation in eyes with central serous chorioretinopathy Focal choroidal excavation in eyes with central serous chorioretinopathy
Focal choroidal excavation in eyes with central serous chorioretinopathy
 
Focal choroidal excavation in eyes with central serous chorioretinopathy
Focal choroidal excavation in eyes with central serous chorioretinopathyFocal choroidal excavation in eyes with central serous chorioretinopathy
Focal choroidal excavation in eyes with central serous chorioretinopathy
 
Retinal vascular occlusions
Retinal vascular occlusions Retinal vascular occlusions
Retinal vascular occlusions
 
Retinal imaging
Retinal imagingRetinal imaging
Retinal imaging
 
Solix brochure
Solix brochureSolix brochure
Solix brochure
 
Criterios diagnosticos en glaucoma
Criterios diagnosticos en glaucomaCriterios diagnosticos en glaucoma
Criterios diagnosticos en glaucoma
 
choroidal-thickness after intravitreal ranibizumab injection
choroidal-thickness after intravitreal ranibizumab injectionchoroidal-thickness after intravitreal ranibizumab injection
choroidal-thickness after intravitreal ranibizumab injection
 
Optical coherence tomography
Optical coherence tomographyOptical coherence tomography
Optical coherence tomography
 
SOLIX Essential Brochure
SOLIX Essential Brochure SOLIX Essential Brochure
SOLIX Essential Brochure
 
CRVO AND NVG MANAGEMENT 2016
CRVO AND NVG MANAGEMENT  2016CRVO AND NVG MANAGEMENT  2016
CRVO AND NVG MANAGEMENT 2016
 
Polypoidal Choroidal
Polypoidal Choroidal Polypoidal Choroidal
Polypoidal Choroidal
 
Dissertation
DissertationDissertation
Dissertation
 
OCTA and Glaucoma Detection.
OCTA and Glaucoma Detection.  OCTA and Glaucoma Detection.
OCTA and Glaucoma Detection.
 

Recently uploaded

Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 
vonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentationvonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentation
Dr.pavithra Anandan
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
HongBiThi1
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
Dr. Ahana Haroon
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
NephroTube - Dr.Gawad
 
pathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathologypathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathology
ZayedKhan38
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
AksshayaRajanbabu
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
Josep Vidal-Alaball
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations   10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations
Traumasoft LLC
 
DECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principlesDECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principles
anaghabharat01
 
Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
LEFLOT Jean-Louis
 
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Kosmoderma Academy Of Aesthetic Medicine
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptxCLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
Government Dental College & Hospital Srinagar
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
MedicoseAcademics
 
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHYMERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
DRPREETHIJAMESP
 

Recently uploaded (20)

Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 
vonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentationvonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentation
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
 
pathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathologypathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathology
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations   10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations
 
DECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principlesDECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principles
 
Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
 
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptxCLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
 
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHYMERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
 

Prognostic value of multiple differential diagnosis of ONH by OCT Angio.pptx

  • 1. Prognostic value of multiple differential diagnosis for optic nerve head by OCT Angio Naglaa Hassan MIOR
  • 2.
  • 3. OCT A Optical Coherence Tomography Angiography (OCT-A) is an imaging modality that can be used to characterize vasculature in various retinal layers, providing quantitative assessment of the microcirculation in the optic nerve head and peripapillary region
  • 4.
  • 5. There are some vascular parameters: vessel density en face vessel density inside disc spacing between large vessels spacing between small vessels outside the disc Normal eyes have a higher vessel density, higher vessel density inside disc, lower spacing between large vessels and small vessels.
  • 6.
  • 7.  NFLP = nerve fiber layer plexus GCLP = ganglion cell layer plexus; ICP = intermediate capillary plexus; DCP = deep capillary plexus.  The NFLP and GCLP can be combined superficial vascular complex (SVC), which contain both large vessels and capillaries.  The ICP and DCP can be combined into deep vascular complex
  • 8.
  • 9.
  • 10. OCT-A can play a pivotal role in the detection, differentiation and monitoring of a wide range of ONH disorders. OCT-A can provides valuable data about the structural changes of the retinal and optic nerve vascular network It can be used for monitoring the disease progression .
  • 11. Color-coded peripapillary OCTA images with four different ONH diseases. A) Compression due to optic nerve head drusen B) Retinal vein occlusion earlier in life C) Chronic non-arteritic anterior ischemic optic neuropathy, D) Advanced glaucoma
  • 12. OCTA in ONH compressive disorders (Drusen)
  • 13. Reduced vascular density consistent with the blue areas on color vascular density map in the both eyes Optic disc Drusen
  • 14. Optic disc drusen ( multi modal imaging )
  • 15. SCP of optic disc (OCTA) with large vessel removal, annulus region of interest, and demarcation of the four quadrants vessel density heat map, and vessel complexity heat map. Vessel area density and vessel complexity index are calculated and represent area occupied by vessel divided by total area and branching complexity of the perfused vasculature, respectively . For ease of comparison, these values are shown on a linear color scale
  • 16. Optic disc drusen does not require treatment, and patients generally have good visual prognosis. There is currently no effective treatment for patients who have gradual loss of visual fields
  • 17. OCTA in Retinal vein occlusion
  • 18. Inside disc Vessel Density (VD) (F), measured inside the optic disc boundary and peripapillary VD, calculated for the region of 750 μm-wide elliptical annulus extending from the optic disc boundary.
  • 19. Optic nerve vessel density changes before (A) and after 4-months (D) from intravitreal anti-(VEGF) injection. Inside disc and peripapillary VD OCTA showed increase in the papillary area in patients affected by CRVO after anti-VEGF therapy. Follow-up OCT vertical scans show a reduction of macular edema from baseline to 4-months (This area could represent a new region of interest to study microvasculature changes concomitant with severe macular edema. Prognostic value
  • 21. Anterior Ischaemic Optic Neuropathy Multimodal analysis of right eye in an AION The fundus examination show a moderately pale optic disc . OCTA scans a reduction of the OCTA whole perfusion density and circumpapillary density (even considering the color-coded flow density map) in the superior Hemifield topographically correlated with the ONH and RNFL damage.
  • 22. In NAION, it has been found that there is significant sectorial capillary density reduction and subsequent decrease in the blood flow to the corresponding region of the optic nerve head.
  • 23. 1st presentation, diffuse edema with normal vascular perfusion was observed then A month later, optic disc atrophy was established with Extensive areas of reduced perfusion are observed in the peripapillary area. Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)
  • 24. MS Optic neuritis can be the initial symptom in approximately 25% of patients up to 50% of MS patients will suffer from at least one episode of optic neuritis during the course of their disease OCT-A findings in MS include significant reduction of the blood flow within the parafoveal region and the optic nerve head. It is still not clear why the blood flow of the retina and optic nerve is reduced in MS patients.
  • 25. Disc OCT-A of a healthy control subject. Right side: Disc OCT-A of an optic neuritis disc showing reduced density of the optic nerve head blood vessel network. This implies reduced blood flow on the optic nerve head.
  • 27. Among the glaucoma ,glaucomatous eyes, the spacing between large vessels was significantly higher in moderate and severe glaucoma grades than in early glaucoma
  • 28. Vessel density of the optic disc, peripapillary Angio flow density map (PAFD) displays loss of the retinal nerve fiber layer in a patient diagnosed with glaucoma.
  • 29.
  • 30.
  • 31.
  • 32.
  • 33.  OCT-A vessel density is lower in glaucoma patients compared with healthy and glaucoma suspects  The Diagnostic accuracy of OCT-A and the ability to noninvasively evaluate the capillary networks shows promise for prognostic value for characterizing glaucomatous retinal vascular changes and may have a role in glaucoma management.  Also determination whether a lower vessel density found in glaucoma patients precedes or follows optic nerve damage and whether this information can be used to improve glaucoma management.
  • 34.
  • 35. A) untreated eye with high intraocular pressure. B) The same eye one month later under combined intraocular pressure lowering medication and with more than 50% intraocular pressure reduction The peripapillary vessel density map shows a clear increase in capillary perfusion Prognostic value
  • 36. 1-OCT-A can play a pivotal role in differentiation and monitoring of a wide range of ONH disorders. 2-OCTA can be used for the development of biomarkers to monitor the disease progression . 3-Not only RNFL analysis. .O.N.H micro vasculature does matter as the same important . 4-O.N.H and peri papillary area could represent a new region of interest to study microvasculature changes. Take home message